VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SUPN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SUPNSupernus Pharmaceuticals, Inc.
$47.41$2.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSUPNPrice History

SUPN logoSupernus Pharmaceuticals, Inc. (SUPN) Stock Price History

Historical prices from 2012 to 2026

$47.41+0.90  (+1.94%)close Jul 1
Returns
1M
+6.6%
3M
-7.0%
YTD
-4.2%
1Y
+50.7%
3Y
+16.9%
5Y
+10.3%
ATH$61.25Jun 2018-22.6%
ATL$4.30Jun 2012pre-split
Avg Vol (50D)645K/ day
52-Week Range$31.37 — $59.68
LowCurrent: $47.41High

Loading 10-year price history...

SUPN Historical Performance

1 YearTotal Return
+50.7%
Price: +50.7%
3 YearsTotal Return
+60.0%
CAGR: +16.9%
Price: +60.0%
5 YearsTotal Return
+63.0%
CAGR: +10.3%
Price: +63.0%
YTD
-4.2%

SUPN Annual Returns

Year-by-year price performance · 2012–2026

Best+92.2%2016
Worst-27.6%2019
Up years12/15
2012+33.5%
2013+3.4%
2014+8.5%
2015+63.5%
2016+92.2%
2017+53.6%
2018-17.9%
2019-27.6%
2020+6.1%
2021+16.0%
2022+18.6%
2023-22.8%
2024+30.4%
2025+36.4%
2026+10.6%
2012 annual price return
+33.5%
2013 annual price return
+3.4%
2014 annual price return
+8.5%
2015 annual price return
+63.5%
2016 annual price return
+92.2%
2017 annual price return
+53.6%
2018 annual price return
-17.9%
2019 annual price return
-27.6%
2020 annual price return
+6.1%
2021 annual price return
+16.0%
2022 annual price return
+18.6%
2023 annual price return
-22.8%
2024 annual price return
+30.4%
2025 annual price return
+36.4%
2026 annual price return
+10.6%
LessMore
Alpha vs S&P 500
1Y+21.7%
3Y-8.5%
5Y-4.7%

Price returns only.

Download Historical Data

3,563 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

SUPN Stock Price Trajectory (2012–2026)

As of July 8, 2026, Supernus Pharmaceuticals, Inc. (SUPN) trades at $47.41, representing a +50.7% return over the past year. The stock has delivered a +63.0% total return over five years (+10.3% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $61.25 on June 29, 2018. From this peak, SUPN has corrected -22.6%, currently trading 3% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers PCRX (+11.2% 1Y), ACAD (+25.5% 1Y), and INVA (+17.7% 1Y), SUPN has outperformed the peer group average. Compare SUPN vs PCRX →

SUPN Historical Price Data · from 2012

Rows 1–50 of 3,563
Date Open High Low Close Volume Change %
2026-07-0146.9847.5345.9947.41885K+1.94%
2026-06-3046.6447.0846.1646.51667K-0.62%
2026-06-2946.7746.8446.2746.80807K-0.09%
2026-06-2644.7547.1244.7546.840+4.67%
2026-06-2544.9445.4644.5044.75683K-0.86%
2026-06-2444.5545.5044.5245.14715K+1.48%
2026-06-2344.7145.4144.4644.48510K0.00%
2026-06-2244.8644.8844.0944.48495K+0.23%
2026-06-1844.0744.5543.6244.38903K+1.84%
2026-06-1743.3744.0142.5043.58523K0.00%
2026-06-1644.0944.2042.4543.58691K-0.64%
2026-06-1543.9944.4442.7443.86818K-1.24%
2026-06-1245.7145.7144.2044.41820K-2.50%
2026-06-1145.0645.8844.4145.55464K+1.02%
2026-06-1045.7246.4744.9845.09368K-1.25%
2026-06-0944.8645.7844.7045.66359K+2.65%
2026-06-0844.9445.5944.3444.48412K-0.60%
2026-06-0544.9445.7344.5944.75544K+0.11%
2026-06-0444.6645.7244.5044.70452K+1.51%
2026-06-0343.9344.9843.4844.03962K-0.08%
2026-06-0244.2544.4743.4544.07668K-1.54%
2026-06-0145.7546.1644.1744.76535K-3.07%
2026-05-2946.4347.1645.9646.18459K-1.43%
2026-05-2846.6347.7445.9246.85601K+0.45%
2026-05-2747.7648.3846.4046.64682K-2.37%
2026-05-2648.4448.5047.4247.77468K-0.91%
2026-05-2249.3849.8348.2048.21490K-2.37%
2026-05-2148.6849.5847.9849.38442K+1.42%
2026-05-2048.2949.2447.6848.69595K+2.25%
2026-05-1948.1348.5247.5247.62574K-1.47%
2026-05-1849.3449.9847.8548.33521K-2.23%
2026-05-1550.8850.8849.1549.43590K-3.46%
2026-05-1451.7352.3550.5851.20359K-0.31%
2026-05-1350.0251.5050.0251.36395K+1.64%
2026-05-1249.6150.5848.8450.53524K+2.35%
2026-05-1151.0451.7449.1349.37664K-4.19%
2026-05-0852.4652.5350.3551.53771K-1.43%
2026-05-0749.7852.5049.7852.281.05M+1.61%
2026-05-0650.6752.9646.8751.451.65M+4.94%
2026-05-0549.0750.5548.1049.031.08M+0.91%
2026-05-0447.5349.0147.3448.591.36M+1.55%
2026-05-0148.0248.3347.1747.85610K-0.31%
2026-04-3048.7549.2447.8548.00702K-1.13%
2026-04-2948.4248.9047.6248.55488K-0.29%
2026-04-2850.0650.1348.1348.69602K-1.56%
2026-04-2749.7350.1849.1349.46689K-0.60%
2026-04-2450.3950.5148.7149.76429K-1.25%
2026-04-2350.7551.1349.4550.39292K+0.20%
2026-04-2249.4250.3149.0150.29384K+2.38%
2026-04-2151.0651.0648.9849.12482K-4.16%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SUPN — Frequently Asked Questions

Quick answers to the most common questions about buying SUPN stock.

How has SUPN stock performed recently?

SUPN returned +50.7% over the past year, beating its 5-year annualized CAGR of +10.3%. The stock trades below its 200-day moving average, confirming the uptrend.

What is SUPN's all-time high price?

Supernus Pharmaceuticals, Inc. reached $61.25 on 2018-06-29. The 52-week high is $59.68. Current 1-year return of +50.7% places the stock closer to historical peaks.

Where can I download SUPN historical price data?

This page provides SUPN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2012-2026, downloadable in CSV format.

447 data points · sampled from 3,563